Intubation. other medical peocedures
Conditions
Interventions
Intervention 1: Dexmedetomidine 1 microgram per kilogram of body weight intravenously over 10 minutes. Intervention 2: Lidocaine (1%), 1.5 milligram per kilogram of body weight intravenously 90 second
Treatment - Drugs
Dexmedetomidine 1 microgram per kilogram of body weight intravenously over 10 minutes.
Lidocaine (1%), 1.5 milligram per kilogram of body weight intravenously 90 seconds before intubation
Fentanyl 2 microgram per kilogram of body weight intravenously
Sponsors
Vice Chancellor Of Research Zahedan University Of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 30-80 years; ASA class II and III; no allergy to the study drugs; lack of BMI=30; lack of diabetes; non pregnancy; lack of asthma; lack of chronic kidney and liver diseases; lack of long QT; lack of addiction. Exclusion criteria: time of intubation for more than 15 seconds; any kind of difficult intubation.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean arterial blood pressure. Timepoint: After intubation and at 1, 3, 5 and 10 minutes before intubation. Method of measurement: With arterial line.;Systolic blood pressure. Timepoint: After intubation and at 1, 3, 5 and 10 minutes before intubation. Method of measurement: With arterial line.;Diastolic blood pressure. Timepoint: After intubation and at 1, 3, 5 and 10 minutes before intubation. Method of measurement: With arterial line.;Heart rate. Timepoint: After intubation and at 1, 3, 5 and 10 minutes before intubation. Method of measurement: Number by SADAT, Alborz B5 Monitoring system. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Dahmardeh
Zahedan University of Medical Sciences
Outcome results
None listed